Vol. 17 No. 1 (2025): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
Published:
January 1, 2025
Review Articles
-
OUTLINE OF IRON METABOLISM, WITH EMPHASIS TO ERYTHROID CELLS iron Metabolism
2411PDF: 1327Html: 1000 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
3181PDF: 1087HTML: 296Suppl. Files: 531 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2607PDF: 1753HTML: 593 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
3051PDF: 1066HTML: 1463 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1807PDF: 1342HTML: 638 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2290PDF: 1671HTML: 615 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2575HTML: 310PDF: 949
Original Articles
-
PREDISPOSING FACTORS TO INFECTIONS IN THALASSEMIA SYNDROME PATIENTS
1917PDF: 1581HTML: 498 -
AN INEXPENSIVE CLINICAL-LABORATORY NOMOGRAM TO PREDICT POST-TREATMENT LUNG DESTRUCTION IN PULMONARY TUBERCULOSIS
686PDF: 339Suppl. Files: 86Html: 72 -
PLASMODIUM VIVAX INFECTIONS IN DUFFY-NEGATIVE INDIVIDUALS: A PARADIGM SHIFT IN INDIAN MALARIA EPIDEMIOLOGY Duffy negative malaria in India
1353PDF: 891HTML: 140 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
578PDF: 283HTML: 123 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
1023PDF: 606Html: 308Suppl. Files: 193 -
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease
1398PDF: 1009HTML: 498 -
COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia
812PDF: 686HTML: 128 -
POST-LOAD PLASMA GLUCOSE INCREASE (PG-GAP) AS A RISK FACTOR FOR DEVELOPING DYSGLYCEMIA IN PATIENTS WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA (Β-TDT): RETROSPECTIVE ANALYSIS OVER 8 YEARS Post load plasma glucose increase and the risk of glucose dysregulation in thalassemia
603PDF: 280HTML: 168 -
The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients
1472PDF: 492HTML: 181 -
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
1098PDF: 1064Suppl. Files: 665HTML: 190 -
SEROLOGICAL AND MOLECULAR DETECTION OF RICKETTSIA SPP STEMMING FROM HEMATOPHAGOUS VECTORS IN PATIENTS WITH MENINGEAL SYNDROME IN NORTHERN ALGERIA RICKETTSIA SPP IN PATIENTS WITH MENINGEAL SYNDROME
903PDF: 818HTML: 197 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1580PDF: 835Suppl. Files: 350Html: 156 -
FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia
811PDF: 302Html: 39 -
COMPARISON OF IL-34, ELASTOGRAPHY, AND BIOPSY IN THE ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS B Evaluating Non-Invasive and Invasive Methods in Liver Fibrosis
625PDF: 371Html: 33 -
GREEK CONSENSUS ON CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATMENT
1535HTML: 186PDF: 909 -
A MULTICENTER ICET-A SURVEY ON ADHERENCE TO ANNUAL ORAL GLUCOSE TOLERANCE TEST (OGTT) SCREENING IN TRANSFUSION-DEPENDENT THALASSEMIA (TDT) PATIENTS - THE EXPERT CLINICIANS’ OPINION ON FACTORS INFLUENCING THE ADHERENCE AND ON ALTERNATIVE STRATEGIES FOR ADHERENCE OPTIMIZATION Survey on adherence to annual OGTT in thalassemia
3002PDF: 1388HTML: 170
Scientific Letters
-
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1381PDF: 1160PDF: 918HTML: 200
Case Reports
Letters to the Editor
-
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1163PDF: 1275HTML: 123 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
928PDF: 541HTML: 245Suppl. Files: 344 -
Antimicrobial Stewardship in a world racked by conflict and uncertainty: A Call for global resilience AMS in conflict areas
429PDF: 194Html: 50 -
Thalidomide treatment for thrombocytopenia secondary to hypersplenism in children with β-thalassemia major: a case series Thalidomide treatment for thrombocytopenia
965PDF: 783HTML: 264 -
Direct oral anticoagulants (DOACs) in the onco-hematologic patients
1135PDF: 1063HTML: 158 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
1202PDF: 881HTML: 613 -
Is laboratory monitoring useful in DOACs management?
925PDF: 860HTML: 123
